STUDY OF MICE IN WHICH THE TGF BETA GENE HAS BEEN DISRUPTED
对 TGF Beta 基因被破坏的小鼠的研究
基本信息
- 批准号:6160969
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Of the three TGF-b isoforms, type 1 TGF-b is both the most abundant in
most tissues and the most acutely regulated in injury, repair, and in
disease pathogenesis. Although they lack any obvious developmental
defects, mice in which the TGF-b1 gene has been knocked out by targeted
disruption die at about 3 weeks of age of multifocal inflammatory
disease. Immunosuppressive treatments including rapamycin,
dexamethasone, anti-CD4, and anti-CD8 can prolong the life of the TGF-b1
null mice. This has enabled study of wound healing in 4-5 week old mice
in which maternally- transferred TGF-b1 has been depleted. Despite the
prominent role of TGF-b1 in wound healing, there is no delay in closure
of incisional wounds of TGF-b1 null mice. However, the rate of formation
and amount of granulation tissue and collagen deposition is reduced
compared to wildtype littermates and scarring is also reduced. The data
show that release of TGF-b1 from platelets is not essential to
initiation of tissue repair and suggest that compensatory mechanisms,
possibly involving other cytokines or other TGF-b isoforms, may overcome
the effects of loss of TGF-b1 in null mice. Other studies in the TGF-b1
null mice have shown suppressed expression of the mRNAs for several
mitochondrially encoded components of the electron-transport chain,
consistent with ultrastructural abnormalities in Golgi and mitochondria
of cells of liver, heart, and lung of TGF-b1 null mice suggestive of an
energy deficit and impaired vesicular transport. Functional studies have
shown that whereas maximal capacity of individual electron chain
components is not altered in the null mice, there is a significant
decrease in the oxidative capacity of heart tissue. Moreover, studies
with hepatocyte cell lines derived from these mice show that null cells
have less than 25% the oxidative rate of wildtype cells. Treatment of
either null or wildtype cells with TGF-b in vitro results in rapid
upregulation of expression of mitochondrial genes. It is yet to be
determined whether such treatment will reverse the deficit in oxidative
metabolism. Present investigations are aimed at determining the
mechanism whereby TGF-b1 regulates cellular energetics and expression
of mitochondrial genes.
在三种TGF-β同种型中,1型TGF-β是最丰富的,
大多数组织和最急性调节损伤,修复,
发病机理虽然他们缺乏明显的发育
缺陷,其中TGF-b1基因已被敲除的小鼠,
破裂在约3周龄多灶性炎性
疾病免疫抑制治疗,包括雷帕霉素,
地塞米松、抗CD4、抗CD8可延长TGF-β 1的寿命
无效小鼠。这使得能够在4 - 5周龄小鼠中研究伤口愈合
其中母体转移的TGF-β 1已经耗尽。尽管
TGF-β 1在伤口愈合中的作用突出,没有延迟闭合
TGF-β 1基因敲除小鼠的切口伤口。然而,
肉芽组织和胶原沉积量减少
与野生型同窝仔相比,瘢痕形成也减少。数据
显示从血小板释放TGF-b1对于
启动组织修复并提示代偿机制,
可能涉及其他细胞因子或其他TGF-β亚型,可以克服
TGF-b1缺失对裸鼠的影响。其他关于TGF-β 1的研究
裸小鼠已经显示了几种基因的mRNA表达受到抑制,
电子传输链的编码组件,
与高尔基体和线粒体的超微结构异常一致
TGF-b1基因敲除小鼠的肝、心和肺细胞中,
能量缺乏和囊泡运输受损。功能性研究
表明,尽管单个电子链的最大容量
在无效小鼠中,组分没有改变,存在显著的
降低心脏组织的氧化能力。此外,研究
来自这些小鼠的肝细胞系显示,
其氧化率低于野生型细胞的25%。治疗
在体外用TGF-b的无效或野生型细胞导致快速的
线粒体基因表达的上调。还有待
确定这种治疗是否会逆转氧化应激的不足,
新陈代谢.目前的调查旨在确定
TGF-β 1调节细胞能量和表达的机制
线粒体基因。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A B ROBERTS其他文献
A B ROBERTS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A B ROBERTS', 18)}}的其他基金
STUDY OF MICE IN WHICH THE TGF BETA GENE HAS BEEN DISRUPTED
对 TGF Beta 基因被破坏的小鼠的研究
- 批准号:
2463689 - 财政年份:
- 资助金额:
-- - 项目类别:
STUDY OF MICE IN WHICH THE TGF BETA 1 GENE HAS BEEN DISRUPTED
对 TGF Beta 1 基因被破坏的小鼠的研究
- 批准号:
3752781 - 财政年份:
- 资助金额:
-- - 项目类别:
BIOLOGY AND RECEPTOR SIGNALLING OF TRANSFORMING GROWTH FACTOR-BETA
转化生长因子-β的生物学和受体信号转导
- 批准号:
5201457 - 财政年份:
- 资助金额:
-- - 项目类别:
BIOLOGY AND MOLECULAR BIOLOGY OF TRANSFORMING GROWTH FACTOR-BETA
转化生长因子-β的生物学和分子生物学
- 批准号:
3853409 - 财政年份:
- 资助金额:
-- - 项目类别:
MECHANISM OF ACTION OF TYPE BETA TRANSFORMING GROWTH FACTOR
β型转化生长因子的作用机制
- 批准号:
4692310 - 财政年份:
- 资助金额:
-- - 项目类别:
NOVEL CHEMOPREVENTIVE AGENTS IN EXPERIMENTAL MAMMARY CARCINOGENESIS
乳腺癌实验中的新型化学预防剂
- 批准号:
6100875 - 财政年份:
- 资助金额:
-- - 项目类别:
BIOLOGY AND MOLECULAR BIOLOGY OF TRANSFORMING GROWTH FACTOR-BETA
转化生长因子-β的生物学和分子生物学
- 批准号:
3838326 - 财政年份:
- 资助金额:
-- - 项目类别:
STRUCTURE/FUNCTION AND SIGNAL TRANSDUCTION PATHWAYS OF TGF BETA
TGF Beta 的结构/功能和信号转导途径
- 批准号:
6160869 - 财政年份:
- 资助金额:
-- - 项目类别:
NOVEL CHEMOPREVENTIVE AGENTS IN EXPERIMENTAL MAMMARY CARCINOGENESIS
乳腺癌实验中的新型化学预防剂
- 批准号:
6160975 - 财政年份:
- 资助金额:
-- - 项目类别:
BIOLOGY AND MOLECULAR BIOLOGY OF TRANSFORMING GROWTH FACTOR-BETA
转化生长因子-β的生物学和分子生物学
- 批准号:
3916749 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
MHC Class II Antigen Presentation In Melanoma: Impact on Immune Recognition
黑色素瘤中 MHC II 类抗原的呈现:对免疫识别的影响
- 批准号:
10674177 - 财政年份:2021
- 资助金额:
-- - 项目类别:
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
- 批准号:
10618790 - 财政年份:2021
- 资助金额:
-- - 项目类别:
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
- 批准号:
10392325 - 财政年份:2021
- 资助金额:
-- - 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
- 批准号:
8360306 - 财政年份:2011
- 资助金额:
-- - 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
- 批准号:
8167705 - 财政年份:2010
- 资助金额:
-- - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
8131116 - 财政年份:2007
- 资助金额:
-- - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7321929 - 财政年份:2007
- 资助金额:
-- - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7673392 - 财政年份:2007
- 资助金额:
-- - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7483748 - 财政年份:2007
- 资助金额:
-- - 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
- 批准号:
7907767 - 财政年份:2007
- 资助金额:
-- - 项目类别: